Key facts
- This page summarizes Michael E. Prevoznik's Form 4 filing for QUEST DIAGNOSTICS INC (DGX).
- 4 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 05 Mar 2025, 16:35.
Michael E. Prevoznik - 03 Mar 2025 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)
- Reporting relationship
- SVP & General Counsel
- Issuer ticker
- DGX
- Reported as of
- 03 Mar 2025
- Net transaction value
- +$646,663
- SEC form
- 4
- Accepted by SEC
- 05 Mar 2025, 16:35:33 UTC
- Prior SEC filing
- 28 Feb 2025
- Next SEC filing
- 19 Mar 2025
- Source filing
- View source filing
- Reporting owner signature
- Sean D. Mersten, Attorney in Fact for Michael E. Prevoznik
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Michael E. Prevoznik filed Form 4 for QUEST DIAGNOSTICS INC (DGX) on 05 Mar 2025.
Change
- Previous filing in this sequence was filed on 28 Feb 2025.
- Current net transaction value: +$646,663.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DGX
transaction
Common Stock
Tax liability
- Transaction value
- $55,944
- Shares
- -322
- Change %
- -0.82%
- Price
- $173.74
- Shares after
- 38,709
- Date
- 03 Mar 2025
- Ownership
- Direct
- Footnotes
- F1
DGX
transaction
Common Stock
Sale
- Transaction value
- $104,068
- Shares
- -592
- Change %
- -1.5%
- Price
- $175.79
- Shares after
- 38,117
- Date
- 04 Mar 2025
- Ownership
- Direct
- Footnotes
- F2
DGX
transaction
Common Stock
Award
- Transaction value
- $1,485,303
- Shares
- +8,549
- Change %
- +22%
- Price
- $173.74
- Shares after
- 46,666
- Date
- 04 Mar 2025
- Ownership
- Direct
- Footnotes
- F3
DGX
transaction
Common Stock
Tax liability
- Transaction value
- $678,628
- Shares
- -3,906
- Change %
- -8.4%
- Price
- $173.74
- Shares after
- 42,760
- Date
- 04 Mar 2025
- Ownership
- Direct
- Footnotes
- F4
DGX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 5,640
- Date
- 03 Mar 2025
- Ownership
- 401(k)/SDCP
- Footnotes
- F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 5 footnotes
Footnote F1
Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.
Footnote F2
This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.
Footnote F3
Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award dated approved in accordance with the requirements of Rule 16b-3(d).
Footnote F4
Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award.
Footnote F5
These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.